These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8366411)

  • 41. Medical grade calcium sulfate hemihydrate versus expanded polytetrafluoroethylene in the treatment of mandibular class II furcations.
    Couri CJ; Maze GI; Hinkson DW; Collins BH; Dawson DV
    J Periodontol; 2002 Nov; 73(11):1352-9. PubMed ID: 12479641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of class II furcation defects using porous hydroxylapatite in conjunction with a polytetrafluoroethylene membrane.
    Lekovic V; Kenney EB; Carranza FA; Danilovic V
    J Periodontol; 1990 Sep; 61(9):575-8. PubMed ID: 2170618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eikenella corrodens osteomyelitis of the spine.
    Bridgman SA; Espley A; McCallum ME; Harper I
    J R Coll Surg Edinb; 1990 Aug; 35(4):263-5. PubMed ID: 2231505
    [No Abstract]   [Full Text] [Related]  

  • 45. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and microbiological evaluation of a bioabsorbable and a nonresorbable barrier membrane in the treatment of periodontal intraosseous lesions.
    Smith MacDonald E; Nowzari H; Contreras A; Flynn J; Morrison J; Slots J
    J Periodontol; 1998 Apr; 69(4):445-53. PubMed ID: 9609375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbial associations of 4 putative periodontal pathogens in Sudanese adult periodontitis patients determined by DNA probe analysis.
    Ali RW; Skaug N; Nilsen R; Bakken V
    J Periodontol; 1994 Nov; 65(11):1053-7. PubMed ID: 7853129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guided tissue regeneration may modulate gene expression in periodontal intrabony defects: a human study.
    Lima LL; Gonçalves PF; Sallum EA; Casati MZ; Nociti FH
    J Periodontal Res; 2008 Aug; 43(4):459-64. PubMed ID: 18503515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of a synthetic skin substitute as a physical barrier to enhance healing in human periodontal furcation defects: a follow-up report.
    Flanary DB; Twohey SM; Gray JL; Mellonig JT; Gher ME
    J Periodontol; 1991 Nov; 62(11):684-9. PubMed ID: 1753321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotic resistance of subgingival species in chronic periodontitis patients.
    Ardila CM; Granada MI; Guzmán IC
    J Periodontal Res; 2010 Aug; 45(4):557-63. PubMed ID: 20546113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pedicle procedure use in the management of regenerative therapy problems.
    Rosen PS; Marks MH; Bowers GM
    Compend Contin Educ Dent; 1997 Nov; 18(11):1073-5, 1078-80, 1082 passim; quiz. PubMed ID: 9533342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of the subgingival microbiota to a chairside test for aspartate aminotransferase in gingival crevicular fluid.
    Wong MY; Lu CL; Liu CM; Hou LT; Chang WK
    J Periodontol; 1999 Jan; 70(1):57-62. PubMed ID: 10052771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guided periodontal tissue regeneration in Class II furcation defects following treatment with a synthetic bioabsorbable barrier.
    Hürzeler MB; Quiñones CR; Caffesse RG; Schüpbach P; Morrison EC
    J Periodontol; 1997 May; 68(5):498-505. PubMed ID: 9182747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term periodontal and microbiological changes following orthognathic surgery.
    Weinspach K; Demling A; Günay H; Geurtsen W; Schwestka-Polly R; Staufenbiel I
    J Craniomaxillofac Surg; 2012 Jul; 40(5):467-72. PubMed ID: 21880501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of a combination therapy to eliminate Porphyromonas gingivalis in refractory periodontitis.
    Collins JG; Offenbacher S; Arnold RR
    J Periodontol; 1993 Oct; 64(10):998-1007. PubMed ID: 8277411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial colonisation during GTR treatment. A longitudinal analysis.
    Sbordone L; Barone A; di Genio M; Ramaglia L
    Minerva Stomatol; 1999 Nov; 48(11):501-8. PubMed ID: 10768009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of pathogenic periodontal microflora in healthy young adult smokers.
    Shiloah J; Patters MR; Waring MB
    J Periodontol; 2000 Apr; 71(4):562-7. PubMed ID: 10807119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and microbiological observations of early polytetrafluoroethylene membrane exposure in guided bone regeneration. Case reports in primates.
    Fritz ME; Eke PI; Malmquist J; Hardwick R
    J Periodontol; 1996 Mar; 67(3):245-9. PubMed ID: 8708956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation of periodontal species after guided tissue regeneration.
    Mombelli A; Lang NP; Nyman S
    J Periodontol; 1993 Nov; 64(11 Suppl):1171-5. PubMed ID: 8295107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimicrobial agents and periodontal disease.
    Goldberg MH
    J Am Dent Assoc; 1992 Feb; 123(2):14, 16. PubMed ID: 1541776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.